| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/07/2009 | US7514433 1H-indole-6-yl-piperazin-1-yl-methanone derivatives |
| 04/07/2009 | US7514432 5-[5-(Benzo[b]thiophen-7-yloxy)-pentyloxy]-2-(tetrahydro-pyran-2-yloxymethyl)-4H-pyran-4-one; antiproliferative and antiangiogenic activities; to treat cancers (such as leukemia), ocular diseases and arthritis; excellent bioavailability and pharmacokinetic properties |
| 04/07/2009 | US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 04/07/2009 | US7514430 Nitrogen compounds such as N-phenyl-N'-{(1R,2S)-2-[(2S)-2-benzyl-6-oxo-morpholin-4-yl-methyl]-cyclohexyl }-urea, used to control chemotactic cytokines, and administered for the prevention of asthma or allergies; inhibition of the migration of eosinophils |
| 04/07/2009 | US7514429 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 04/07/2009 | US7514424 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, visceral pain, neurogenic inflammation, asthma, micturition disorders such as urinary incontinence and nociception; reductive hydrogenation |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/07/2009 | CA2393757C Cycloamine ccr5 receptor antagonists |
| 04/07/2009 | CA2381243C 1-cycloalkylpyrazoyl-benzoyl derivatives |
| 04/07/2009 | CA2373880C Isoquinoline derivatives or salts thereof |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2352505C Epothilone derivatives and their use as antitumor agents |
| 04/07/2009 | CA2352503C Il-5 inhibiting 6-azauracil derivatives |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009042694A1 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
| 04/02/2009 | WO2009042485A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | WO2009042098A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition |
| 04/02/2009 | WO2009041715A1 Method of producing benzoxazinone-based compound |
| 04/02/2009 | WO2009041567A1 Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 04/02/2009 | WO2009041559A1 Indazole acrylic acid amide compound |
| 04/02/2009 | WO2009041072A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient |
| 04/02/2009 | WO2009040410A1 Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors |
| 04/02/2009 | WO2009040314A2 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2 |
| 04/02/2009 | WO2009040290A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 04/02/2009 | WO2009014910A3 N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders |
| 04/02/2009 | WO2009011880A3 Heterocyclic modulators of pkb |
| 04/02/2009 | WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders |
| 04/02/2009 | US20090088570 Organic electroluminescent device |
| 04/02/2009 | US20090088490 Two-photon absorption recording material containing dye having polymerizable group |
| 04/02/2009 | US20090088452 Indole Orexin Receptor Antagonists |
| 04/02/2009 | US20090088450 5-ht7 receptor antagonists |
| 04/02/2009 | US20090088442 Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism |
| 04/02/2009 | US20090088432 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors |
| 04/02/2009 | US20090088431 Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| 04/02/2009 | US20090088430 hydroxysteroid reductase inhibitors such as 4-{(R)-3-[3,5-Dichloro-4'-(4-trifluoromethyl-piperidine-1-carbonyl)-biphenyl-4-ylmethyl]-2-oxo-pyrrolidin-1-yl}-piperidine-1-carboxylic acid methyl ester, used for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia and metabolic syndrome |
| 04/02/2009 | US20090088428 (R)-3-(3,5-Dichloro-4'-morpholin-4-yl-biphenyl-4-ylmethyl)-1-(4,5,6,7-tetrahydro-1H-benzoimidazol-5-yl)-pyrrolidin-2-one for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | DE102007045476A1 Neue heteroarylsubstituierte Acetonderivate, geeignet zur Hemmung der Phospholipase A2 New heteroaryl acetone derivatives useful for inhibiting phospholipase A2 |
| 04/02/2009 | CA2701053A1 Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700797A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition |
| 04/02/2009 | CA2700539A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | CA2700113A1 Indazole acrylic acid amide compound |
| 04/02/2009 | CA2699787A1 (3-hydroxy-4-amino-butan-2-yl)-3-(2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
| 04/02/2009 | CA2699697A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 04/01/2009 | EP2042498A1 Crystal of benzoxadiazole derivative |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2041128A2 Substituted gamma lactams as therapeutic agents |
| 04/01/2009 | EP2041127A2 Indole compounds |
| 04/01/2009 | EP2041126A1 Indole compounds having affinity to the ep1 receptor |
| 04/01/2009 | EP2041125A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 04/01/2009 | EP2041119A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof |
| 04/01/2009 | EP2041116A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 04/01/2009 | EP2041115A1 New pyridine analogues |
| 04/01/2009 | EP2041113A1 Novel pyridazine derivatives |
| 04/01/2009 | EP2041112A1 New pyridine analogues |
| 04/01/2009 | EP2041111A1 New pyridine analogues |
| 04/01/2009 | EP2041089A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP2040698A2 Oxime compounds and the use thereof |
| 04/01/2009 | EP2040546A2 Tyrosine kinase inhibitors |
| 04/01/2009 | EP1755585A4 Transthyretin stabilization |
| 04/01/2009 | EP1653961A4 Inhibitors of akt activity |
| 04/01/2009 | EP1513530A4 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 04/01/2009 | EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors |
| 04/01/2009 | CN101400677A Compounds |
| 04/01/2009 | CN101400675A Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments |
| 04/01/2009 | CN101400673A Heterobicyclic carboxamides as inhibitors for kinases |
| 04/01/2009 | CN101400668A 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors |
| 04/01/2009 | CN101400662A Substituted isoxazoline compound and pest control agent |
| 04/01/2009 | CN100473648C 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 04/01/2009 | CN100473381C Use of epothilones in the treatment of brain diseases associated with proliferative processes |
| 03/31/2009 | US7511145 Bicyclic heteroaryl derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511071 Thioamide derivatives as progesterone receptor modulators |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511046 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
| 03/31/2009 | US7511045 Dihydrothienopyrimidines; gastrointestinal disorders; cancer |
| 03/31/2009 | US7511044 Vanilloid receptor ligands and their use in treatments |
| 03/31/2009 | US7511042 1-[5-(5-tert-Butyl-2-methoxy-3-methylsulfamoyl-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2,2-dimethyl-propyl)-amide; small molecule cytokine inhibitor; optimized efficacy, pharmacokinetic; antiinflammatory agent, osteoarthritis, asthma, gastrointestinal, respiratory disorder |
| 03/31/2009 | US7511038 Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/26/2009 | WO2009039135A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 03/26/2009 | WO2009039134A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | WO2009039127A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | WO2009038974A1 Compounds and compositions as modulators of gpr119 activity |
| 03/26/2009 | WO2009038879A2 Stem cell differentiating agents and uses therefor |
| 03/26/2009 | WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009037343A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/26/2009 | WO2009037296A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037294A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037293A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037222A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | WO2009037155A1 Electroluminescent device |